written on 26.03.2014
Tags:
,

Five questions for Novartis India's MD

TAGS: ,

Novartis India's vice chairman and managing director Ranjit Shahani once joked that almost every passenger even on a "Virar fast local" knows about the company and its anticancer, Glivec (imatinib mesylate), with the backdrop of the Supreme Court ruling…

Latest Report